UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 24, 2023
Form:S-3
CIK:0001133416
Company Name:GALECTIN THERAPEUTICS INC
File Number:333-271278
Galectin Therapeutics (NASDAQ:GALT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Galectin Therapeutics.
Galectin Therapeutics (NASDAQ:GALT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Galectin Therapeutics.